Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Saadeh, Ghandi, M.D.
EIR
•Saadeh, Ghandi, M.D.•February 4, 2009

Saadeh, Ghandi, M.D. – FDA EIR, Feb 4, 2009

Record Details

An FDA inspection was conducted at the clinical research site of Dr. Ghandi M. Saadeh, M.D., located in Norfolk, VA, associated with Sentara Medical Group/Norfolk Diagnostic Center. The inspection, which spanned from December 8, 2008, to February 4, 2009, focused on three clinical research protocols involving investigational new drugs, under the FDA's Clinical Investigators Compliance Program 7348.811. The inspection revealed significant violations related to the integrity of study data and conduct. Key issues included the failure to maintain adequate and accurate case histories, missing or photocopied subject diaries with allegations of fabrication, and unaccounted-for study medications. Furthermore, the report documented instances of fabricated laboratory results, enrollment of subjects taking prohibited medications, and broader scientific misconduct such as fabricating source documents, electronic case report forms, and falsifying diaries and enrollment criteria. These issues led to the premature discontinuation of Dr. Saadeh's participation in two of the three clinical studies by their respective sponsors. During the close-out meeting, Dr. Saadeh acknowledged and agreed with all findings presented in the FDA 483 Inspectional Observations, stating he was already aware of the problems through internal audits. He committed to implementing standard operating procedural changes. While a formal response to the FDA 483 was noted as the site's prerogative, the seriousness of the findings underscores the necessity for comprehensive corrective actions to ensure compliance with good clinical practices.

Company
Saadeh, Ghandi, M.D.
Inspection date
February 4, 2009
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Barbara A. Stebler (company_representative)
  • Kimberly A. Dorsch (company_representative)
  • Andrea Slavin (issuing_officer)
  • Ghandi M. Saadeh (recipient)
  • Stephen C. Eason (investigator)
View Company Profile

ID · 1d2bb135-2b15-4a91-8d53-b58388b2c3c9

Violation Codes4
21 CFR 312.6021 CFR 312.62(a)21 CFR 312.62(b)21 CFR 312

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Saadeh, Ghandi, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.